Cardiovascular Anastomosis Devices Market Size & Growth Forecast 2027–2036, By Segments (Product Type, End-Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cardiovascular Anastomosis Devices Market size was estimated at USD 2.02 billion in 2026 and is projected to grow at a 6.18% CAGR from 2027 to 2036, reaching USD 3.68 billion by 2036. The industry revenue for 2027 is calculated at USD 2.13 billion.
Get more details on this report
Request Free Sample ReportCardiovascular Anastomosis Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America accounted for 45.58% of the market in 2026, supported by high cardiac surgery volumes, advanced hospital infrastructure, and widespread adoption of specialized surgical devices.
- Asia Pacific is projected to grow at a 7.46% CAGR as surgical access expands, cardiac treatment capacity increases, and healthcare providers adopt advanced cardiovascular surgical technologies.
Segment Momentum
- Manual devices hold a 60.92% share due to strong surgeon familiarity, established workflows, and broad applicability across procedures where direct control remains essential in vessel connection techniques.
- Automatic devices are growing fastest as hospitals seek faster, more standardized vessel joining methods that improve procedural efficiency and consistency in complex cardiovascular surgeries.
Market Expansion Drivers
- Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally.
- Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization.
- Medical technology innovation improving graft patency and surgical precision in cardiac procedures.
Leading Market Participants
- Key players in the cardiovascular anastomosis devices market include Abbott Laboratories (United States), Medtronic plc (Ireland), B. Braun Melsungen AG (Germany), Getinge AB (Sweden), Terumo Corporation (Japan), Edwards Lifesciences Corporation (United States), Johnson & Johnson (Ethicon Inc.) (United States), LivaNova PLC (United Kingdom), Peters Surgical (France), MicroPort Scientific Corporation (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 2.02 billion
- 2027 Estimated Market Size: USD 2.13 billion.
- Projected Market Size: USD 3.68 billion by 2036
- Growth Forecast: 6.18% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Manual (Product Type) | Hospitals (End-Use)
- Emerging Opportunity Segment: Automatic (Product Type) | Specialty Clinics (End-Use)
Market Growth Drivers and Industry Trends
Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally
The growing burden of cardiovascular diseases is increasing the need for surgical procedures that restore or maintain blood flow in affected vessels, supporting cardiovascular anastomosis devices market growth. As more patients require coronary artery bypass grafting and other vascular reconstruction procedures, surgeons increasingly depend on reliable anastomosis solutions to establish secure connections between blood vessels and grafts. The rising incidence of conditions such as coronary artery disease, peripheral vascular complications, and other cardiovascular disorders is also expanding the pool of patients requiring operative intervention. Greater emphasis on timely treatment and improved surgical outcomes is encouraging healthcare providers to adopt devices that can facilitate consistent vessel joining, reduce procedural complexity, and support efficient tissue handling during cardiac operations.
Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization
The shift toward less invasive cardiac interventions is creating additional opportunities for cardiovascular anastomosis devices market expansion as healthcare providers seek techniques that can reduce surgical trauma and recovery requirements. Minimally invasive and off-pump procedures require precise vascular connections while limiting manipulation of the heart and surrounding tissues, increasing the importance of specialized anastomosis technologies. Devices designed to support controlled and efficient vessel joining can help surgeons manage restricted operative access and maintain procedural accuracy without relying entirely on conventional open-heart approaches. Growing clinical interest in reducing blood loss, shortening hospitalization, and improving postoperative recovery is encouraging wider use of anastomosis solutions compatible with evolving cardiac surgical techniques.
Medical technology innovation improving graft patency and surgical precision in cardiac procedures
Advances in medical device engineering are strengthening the cardiovascular anastomosis devices market by addressing the need for more precise vessel connections and durable graft performance. Innovations in device design, deployment mechanisms, and surgical guidance are helping clinicians achieve greater consistency when connecting grafts to blood vessels, while improvements in material and mechanical characteristics can support secure anastomotic sites. Technologies that simplify positioning, reduce the potential for technical variability, and improve visualization during procedures are particularly relevant to complex cardiac surgeries. Continued development of solutions focused on maintaining graft patency and minimizing complications is encouraging surgeons and healthcare institutions to incorporate newer anastomosis technologies into cardiac procedure workflows.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing cardiovascular disease prevalence driving higher surgical intervention demand globally | 2.20% | High | North America, Europe | High | Near Term |
| Rising adoption of minimally invasive and off-pump cardiac procedures improving device utilization | 2.00% | High | North America, Europe | Medium | Mid Term |
| Medical technology innovation improving graft patency and surgical precision in cardiac procedures | 1.80% | High | North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the cardiovascular anastomosis devices market at 45.58% in 2026, supported by advanced cardiovascular care infrastructure, established surgical capabilities, and strong adoption of sophisticated medical technologies. The region's healthcare systems emphasize minimally invasive and precision-oriented procedures, creating demand for devices that can support efficient vascular connections during complex cardiovascular interventions. Continued investment in surgical innovation and specialized clinical infrastructure further strengthens the regional market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing access to cardiovascular procedures, and rising demand for advanced surgical technologies. Improvements in hospital capabilities and growing investment in specialized cardiovascular care are supporting greater adoption of anastomosis devices. Increasing awareness of advanced treatment options and the modernization of healthcare facilities are also creating favorable conditions for broader use of these devices across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Cardiac Procedure FocusGermany's market is supported by specialized cardiac centers seeking technologies that improve surgical precision and patient outcomes. Manufacturers in Germany are focusing on device reliability and compatibility with advanced cardiovascular procedures performed in highly specialized healthcare settings.
France 🇫🇷
Specialized Cardiac Care IntegrationFrance's cardiovascular anastomosis devices market is supported by established cardiac treatment networks and growing interest in procedural innovation. Healthcare institutions in France are prioritizing technologies that enhance surgical consistency and support complex cardiovascular interventions.
Italy 🇮🇹
Cardiovascular Procedure ModernizationItaly continues to adopt cardiovascular anastomosis devices as cardiac centers seek tools that improve procedural outcomes and streamline surgery. The market in Italy is increasingly focused on technologies that support precision in vascular reconstruction and facilitate advanced cardiac treatment approaches.
Japan 🇯🇵
Efficiency-Oriented Surgical SolutionsIn Japan, cardiovascular anastomosis devices are gaining attention as healthcare providers pursue technologies that shorten procedure times and support an aging patient population. The market in Japan is emphasizing devices that facilitate standardized surgical performance and reduce procedural complexity.
South Korea 🇰🇷
Minimally Invasive Cardiac ExpansionSouth Korea is increasingly integrating cardiovascular anastomosis devices into advanced cardiac surgery programs and minimally invasive procedures. Hospitals in South Korea are investing in technologies that improve surgical efficiency and align with broader efforts to modernize cardiovascular care capabilities.
United States 🇺🇸
Advanced Surgical Technology AdoptionThe U.S. cardiovascular anastomosis devices market is driven by demand for technologies that improve procedural efficiency and support minimally invasive cardiac interventions. Healthcare providers in the U.S. are increasingly adopting devices that reduce operative complexity and enhance consistency in vascular connections.
Segment Leadership and Growth Trends
Cardiovascular Anastomosis Devices Market Share (%), by Product Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Type Segment Analysis: Manual (Largest Segment) vs Automatic (Fastest-Growing Segment)
Manual devices held the largest share of the cardiovascular anastomosis devices market in 2026, accounting for 60.92% of the market. Their established use in cardiovascular procedures is supported by familiarity among surgeons and the ability to provide direct control during delicate vessel-joining procedures. Manual techniques can also offer flexibility in adapting to variations in vessel anatomy and surgical conditions. Continued demand for cardiovascular interventions and the established role of surgeon-controlled approaches in complex procedures are sustaining the segment's leading position.
Automatic devices are gaining adoption as healthcare providers increasingly seek technologies that can improve procedural consistency, simplify complex surgical steps, and potentially reduce technical demands. Automation can support more standardized anastomosis procedures while contributing to workflow efficiency and precision. Growing interest in minimally invasive and technologically advanced cardiovascular interventions is encouraging investment in automated surgical technologies, creating stronger growth opportunities for this segment.
End-Use Segment Analysis: Hospitals (Largest Segment) vs Specialty Clinics (Fastest-Growing Segment)
Hospitals represented the largest end-use segment of the cardiovascular anastomosis devices market in 2026, with a 61.11% share. Hospitals remain central to cardiovascular care because they provide advanced surgical infrastructure, specialized operating facilities, intensive monitoring, and multidisciplinary clinical expertise. The concentration of complex cardiovascular procedures within hospital settings supports sustained demand for anastomosis devices. Continued investment in surgical capabilities and the need to manage patients requiring advanced cardiovascular interventions further reinforce hospital-based adoption.
Specialty clinics are experiencing faster growth as cardiovascular care increasingly incorporates specialized treatment settings designed to improve accessibility and procedural efficiency. These facilities can offer focused expertise and streamlined care pathways for selected cardiovascular interventions. Expansion of specialized outpatient and ambulatory care models, together with efforts to reduce treatment burdens and improve patient convenience, is creating greater opportunities for anastomosis device adoption in specialty clinics.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product Type | Automatic, Manual | Manual | Automatic |
| End-Use | Hospitals, Ambulatory Surgical Centers, Specialty Clinics | Hospitals | Specialty Clinics |
Competitive Landscape and Market Positioning
Top players in the cardiovascular anastomosis devices market:
1. Abbott Laboratories (United States)
2. Medtronic plc (Ireland)
3. B. Braun Melsungen AG (Germany)
4. Getinge AB (Sweden)
5. Terumo Corporation (Japan)
6. Edwards Lifesciences Corporation (United States)
7. Johnson & Johnson (Ethicon Inc.) (United States)
8. LivaNova PLC (United Kingdom)
9. Peters Surgical (France)
10. MicroPort Scientific Corporation (China)
Continuous innovation in cardiovascular surgery is advancing the cardiovascular anastomosis devices market, with research focused on precision surgical devices, minimally invasive procedures, and improved vessel connection technologies. These developments are enhancing procedural efficiency and patient outcomes.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| B. Braun Melsungen AG (Germany) | |||||||
| Getinge AB (Sweden) | |||||||
| Terumo Corporation (Japan) | |||||||
| Edwards Lifesciences Corporation (United States) | |||||||
| Johnson & Johnson (Ethicon Inc.) (United States) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Peters Surgical (France) | |||||||
| MicroPort Scientific Corporation (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| GT Metabolic Solutions, Inc. | Sep-24 | GT Metabolic Solutions received FDA De Novo marketing authorization for its MagDI System designed for side-to-side duodeno-ileal anastomosis in bariatric and metabolic surgery. The approval enables commercialization of a novel anastomosis technology intended to improve gastrointestinal surgical outcomes and expand minimally invasive procedural capabilities in advanced cardiovascular and metabolic surgical applications. |
| Exero Medical | May-24 | Exero Medical initiated an international pivotal multi-center clinical study for its xBar system, an FDA breakthrough-designated device using post-surgical tissue monitoring technology. The study evaluates its ability to provide real-time healing data after gastrointestinal surgery, supporting improved postoperative management and earlier detection of complications that may be relevant to anastomosis-related surgical recovery pathways. |
| Intuitive Surgical Inc. | Jun-21 | Intuitive Surgical launched the SureForm surgical stapler equipped with SmartFire technology, integrating software-driven control to improve staple formation and tissue compression consistency. The product enhances robotic-assisted surgical precision and supports improved outcomes in tissue anastomosis procedures through automated adjustment of stapling force during operations. |
| Johnson & Johnson | Mar-21 | Johnson & Johnson introduced the ECHELON+ powered surgical stapler designed to improve surgical precision through more uniform tissue compression and optimized staple formation. The device aims to reduce surgical complications and enhance consistency in tissue anastomosis procedures, strengthening the company’s surgical device portfolio within minimally invasive cardiovascular and general surgery applications. |
| Medtronic plc | Mar-19 | Medtronic plc acquired EPIX Therapeutics, a catheter-based cardiac ablation system developer, expanding its cardiac arrhythmia treatment portfolio. The acquisition strengthens Medtronic’s cardiovascular intervention capabilities by integrating advanced ablation technologies into its existing suite of cardiac surgical and electrophysiology tools, enhancing its position in minimally invasive cardiovascular treatment solutions. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cardiovascular Anastomosis Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Procedure Type | Coronary Artery Bypass Grafting, Peripheral Vascular Bypass, Aortic and Other Cardiovascular Procedures |
| Vessel Type | Coronary Arteries, Peripheral Arteries, Aorta and Major Vessels, Other Cardiovascular Vessels |
| Clinical Indication | Coronary Artery Disease, Peripheral Arterial Disease, Aortic Disease, Congenital and Other Cardiovascular Conditions |
Cardiovascular Anastomosis Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Hospital Procurement and Purchasing Strategy |
|
| Clinical Adoption and Surgeon Preferences |
|
| Reimbursement and Market Access Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow big is the cardiovascular anastomosis devices market?
How will the cardiovascular anastomosis devices industry grow in terms of size and CAGR by 2036?
How is the shift toward minimally invasive cardiac procedures affecting adoption of cardiovascular anastomosis devices?
Why is medical technology innovation strategically important in the cardiovascular anastomosis devices market?
Why do manual devices dominate the cardiovascular anastomosis devices market?
What is driving the growth of automatic devices in cardiovascular anastomosis procedures?
Why is North America the leading region in the cardiovascular anastomosis devices market?
What is driving growth in the cardiovascular anastomosis devices market across Asia Pacific?
Who are the major participants shaping the cardiovascular anastomosis devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization